599 related articles for article (PubMed ID: 27166634)
61. Characterization of periostin isoform pattern in non-small cell lung cancer.
Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
[TBL] [Abstract][Full Text] [Related]
62. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways.
Zhou F; Nie L; Feng D; Guo S; Luo R
Oncol Rep; 2017 Sep; 38(3):1857-1866. PubMed ID: 28731178
[TBL] [Abstract][Full Text] [Related]
63. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.
Lv T; Yuan D; Miao X; Lv Y; Zhan P; Shen X; Song Y
PLoS One; 2012; 7(4):e35065. PubMed ID: 22493729
[TBL] [Abstract][Full Text] [Related]
64. miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer.
Liu B; Wang Z; Cheng S; Du L; Yin Y; Yang Z; Zhou J
Mol Med Rep; 2019 Aug; 20(2):1418-1428. PubMed ID: 31173238
[TBL] [Abstract][Full Text] [Related]
65. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
Chen Y; Yang S; Zhou H; Su D
Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
[TBL] [Abstract][Full Text] [Related]
66. FOXO1 Inhibits Tumor Cell Migration via Regulating Cell Surface Morphology in Non-Small Cell Lung Cancer Cells.
Gao Z; Liu R; Ye N; Liu C; Li X; Guo X; Zhang Z; Li X; Yao Y; Jiang X
Cell Physiol Biochem; 2018; 48(1):138-148. PubMed ID: 30001537
[TBL] [Abstract][Full Text] [Related]
67. Cigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMT.
Li D; Zhang L; Zhou J; Chen H
Lung Cancer; 2016 Mar; 93():35-42. PubMed ID: 26898612
[TBL] [Abstract][Full Text] [Related]
68. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
69. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
[TBL] [Abstract][Full Text] [Related]
70. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines.
Tauler J; Zudaire E; Liu H; Shih J; Mulshine JL
Cancer Res; 2010 Sep; 70(18):7137-47. PubMed ID: 20807810
[TBL] [Abstract][Full Text] [Related]
71. Knockdown of SP1/Syncytin1 axis inhibits the proliferation and metastasis through the AKT and ERK1/2 signaling pathways in non-small cell lung cancer.
Li X; Fu Y; Xia X; Zhang X; Xiao K; Zhuang X; Zhang Y
Cancer Med; 2019 Sep; 8(12):5750-5759. PubMed ID: 31397118
[TBL] [Abstract][Full Text] [Related]
72. MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase.
Lei T; Zhu Y; Jiang C; Wang Y; Fu J; Fan Z; Qin H
Mol Med Rep; 2016 Aug; 14(2):1255-62. PubMed ID: 27277534
[TBL] [Abstract][Full Text] [Related]
73. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
74. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
75. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
[TBL] [Abstract][Full Text] [Related]
76. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J
Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657
[TBL] [Abstract][Full Text] [Related]
77. miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
Qin Q; Wei F; Zhang J; Li B
Oncol Rep; 2017 Feb; 37(2):823-830. PubMed ID: 28075475
[TBL] [Abstract][Full Text] [Related]
78. VEGFC/VEGFR3 axis mediates TGFβ1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells.
Duan L; Ye L; Zhuang L; Zou X; Liu S; Zhang Y; Zhang L; Jin C; Huang Y
PLoS One; 2018; 13(7):e0200452. PubMed ID: 29995950
[TBL] [Abstract][Full Text] [Related]
79. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
80. CircRNA circ_0067934 silencing inhibits the proliferation, migration and invasion of NSCLC cells and correlates with unfavorable prognosis in NSCLC.
Wang J; Li H
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3053-3060. PubMed ID: 29863250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
